Advertisement

Management of Local Anesthetic Systemic Toxicity (LAST)

  • Preetham J. Suresh
Chapter

Abstract

Local anesthetic system toxicity (LAST) is an infrequent but potentially life-threatening emergency that requires immediate and decisive steps. Some of these interventions are unique to LAST, and interestingly some interventions that are routine in other scenarios are potentially contraindicated in LAST. A clear understanding of the indications and risks associated with the specific treatments is required in order to effectively deliver care during this scenario. This chapter outlines these aspects in the context of an obstetric scenario.

Keywords

Local anesthetics Bupivacaine Lidocaine Lipid solubility pKa Systemic toxicity LAST Checklist Pregnancy Fetus Seizure Lipid emulsion Lipid sink Metabolic hypothesis Propofol Cardiac arrest Hypoxia Acidosis Resuscitation Epinephrine Vasopressin 

References

  1. 1.
    Neal JM, Bernards CM, Butterworth JF, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:152–61.CrossRefGoogle Scholar
  2. 2.
    Cousins MJ. Cousins & Bridenbaugh’s neural blockade in clinical anesthesia and pain medicine. 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2009.Google Scholar
  3. 3.
    Di Gregorio G, et al. Clinical presentation of local anesthetic systemic toxicity: a review of published cases, 1979 to 2009. Reg Anesth Pain Med. 2010;35(2):181–7.CrossRefGoogle Scholar
  4. 4.
    Gitman M, Barrington MJ. Local anesthetic systemic toxicity. Reg Anesth Pain Med:1.Google Scholar
  5. 5.
    Neal JM, Barrington MJ, Fettiplace MR, Gitman M, Memtsoudis SG, Mörwald EE, Rubin DS, Weinberg G. The Third American Society of Regional Anesthesia and pain medicine practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 43(2):113–23.CrossRefGoogle Scholar
  6. 6.
    Finucane BT. Complications of regional anesthesia. 2nd ed. New York: Springer; 2007.CrossRefGoogle Scholar
  7. 7.
    Rogers MC, Tinker IH, Covino BG, et al. Principles and practice of anesthesiology. Philadelphia: Mosby; 1993.Google Scholar
  8. 8.
    Groban L, et al. Cardiac resuscitation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine in anesthetized dogs. Anesth Analg. 2001;92(1):37–43.CrossRefGoogle Scholar
  9. 9.
    Barash PG. Clinical anesthesia. 6th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2009.Google Scholar
  10. 10.
    Garrett R, Kaura V, Kathawaroo S. Intravenous lipid emulsion therapy–the fat of the land. Trends Anaesthesia Crit Care. 2013;3(6):336–41.CrossRefGoogle Scholar
  11. 11.
    Fettiplace MR, Weinberg G. The mechanisms underlying lipid resuscitation therapy. Reg Anesth Pain Med. 43(2):138–49.CrossRefGoogle Scholar
  12. 12.
    Hori K, et al. The effect of lipid emulsion on intracellular bupivacaine as a mechanism of lipid resuscitation: an electrophysiological study using voltage-gated proton channels. Anesth Analg. 2013;117(6):1293–301.CrossRefGoogle Scholar
  13. 13.
    Aumeier C, Kasdorf B, Gruber M, Busse H, Wiese CH, Zink W, et al. Lipid emulsion pretreatment has different effects on mepivacaine and bupivacaine cardiac toxicity in an isolated rat heart model. Br J Anaesth. 2014;112(4):735–41.CrossRefGoogle Scholar
  14. 14.
    Zausig YA, Zink W, Keil M, Sinner B, Barwing J, Wiese CH, et al. Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest. Anesth Analg. 2009;109(4):1323–6.CrossRefGoogle Scholar
  15. 15.
    Brull SJ. Lipid emulsion for the treatment of local anesthetic toxicity: patient safety implications. Anesth Analg. 2008;106(5):1337–9.CrossRefGoogle Scholar
  16. 16.
    Mirtallo JM, et al. State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother. 2010;44(4):688–700.CrossRefGoogle Scholar
  17. 17.
    Hiller DB, Di Gregorio G, Kelly K, Ripper R, Edelman L, Boumendjel R, et al. Safety of high volume lipid emulsion infusion: a first approximation of LD50 in rats. Reg Anesth Pain Med. 2010;35(2):140–4.CrossRefGoogle Scholar
  18. 18.
    Hamshaw-Thomas A, Rogerson N, Reynolds F. Placental transfer of bupivacaine, pethidine and lignocaine in the rabbit. Effect of umbilical flow rate and protein content. BJOG Int J Obstet Gynaecol. 1985;92(7):706–13.CrossRefGoogle Scholar
  19. 19.
    Barson AJ, Chistwick ML, Doig CM. Fat embolism in infancy after intravenous fat infusions. Arch Dis Child. 1978;53(3):218–23.CrossRefGoogle Scholar
  20. 20.
    Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–67.CrossRefGoogle Scholar
  21. 21.
    Miller RD. Miller’s anesthesia. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2010.Google Scholar
  22. 22.
    Spence AG. Lipid reversal of central nervous system symptoms of bupivacaine toxicity. Anesthesiology. 2007;1079(3):516–7.CrossRefGoogle Scholar
  23. 23.
    Bern S, Weinberg G. Local anesthetic toxicity and lipid resuscitation in pregnancy. Curr Opin Anesthesiol. 2011;24(3):262–7.CrossRefGoogle Scholar
  24. 24.
    Caruso A, et al. Pregnancy outcome and total parenteral nutrition in malnourished pregnant women. Fetal Diagn Ther. 1998;13(3):136–40.CrossRefGoogle Scholar
  25. 25.
    Jasnosz KM, Pickeral JJ, Graner S. Fat deposits in the placenta following maternal total parenteral nutrition with intravenous lipid emulsion. Arch Pathol Lab Med. 1995;119(6):555–7.PubMedGoogle Scholar
  26. 26.
    Puntis JW, Rushton DI. Pulmonary intravascular lipid in neonatal necropsy specimens. Arch Dis Child. 1991;66(1):26–8.CrossRefGoogle Scholar
  27. 27.
    Lloyd TR, Boucek MM. Effect of intralipid on the neonatal pulmonary bed: an echographic study. J Pediatr. 1986;108(1):130–3.CrossRefGoogle Scholar
  28. 28.
    Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35(2):188–93.CrossRefGoogle Scholar
  29. 29.
    Moore DC, Crawford RD, Scurlock JE. Severe hypoxia and acidosis following local anesthetic-induced convulsions. Anesthesiology. 1980;53(3):259–60.CrossRefGoogle Scholar
  30. 30.
    Stock MC, Downs JB, McDonald JS, Silver MJ, McSweeney TD, Fairley DS. The carbon dioxide rate of rise in awake apneic humans. J Clin Anesth. 1988;1(2):96–103.CrossRefGoogle Scholar
  31. 31.
    Kotelko DM, et al. Bupivacaine-induced cardiac arrhythmias in sheep. Anesthesiology. 1984;60:10–8.CrossRefGoogle Scholar
  32. 32.
    Rosen MA, Thigpen JW, Shnider SM, Foutz SE, Levinson G, Koike M. Bupivacaine-induced cardiotoxicity in hypoxic and acidotic sheep. Anesth Analg. 1985;64(11):1089–96.CrossRefGoogle Scholar
  33. 33.
    Weinberg GL, et al. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88(4):1071–5.CrossRefGoogle Scholar
  34. 34.
  35. 35.
    Neal JM, Hsiung RL, Mulroy MF, Halpern BB, Dragnich AD, Slee AE. ASRA checklist improves trainee performance during a simulated episode of local anesthetic systemic toxicity. Reg Anesth Pain Med. 2012;37(1):8–15.CrossRefGoogle Scholar
  36. 36.
    Feinstein DL, et al. Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology. 2008;108(5):907–13.CrossRefGoogle Scholar
  37. 37.
    Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med. 2012;37(1):16–8.CrossRefGoogle Scholar
  38. 38.
    Hicks SD, et al. Lipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest. Anesthesiology. 2009;111(1):138–46.CrossRefGoogle Scholar
  39. 39.
    Mayr VD, et al. A comparison of the combination of epinephrine and vasopressin with lipid emulsion in a porcine model of asphyxial cardiac arrest after intravenous injection of bupivacaine. Anesth Analg. 2008;106(5):1566–71.CrossRefGoogle Scholar
  40. 40.
    Di Gregorio G, Schwartz D, Ripper R, Kelly K, Feinstein DL, Minshall RD, et al. Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest*. Crit Care Med. 2009;37(3):993–9.CrossRefGoogle Scholar
  41. 41.
    Mayr VD, Mitterschiffthaler L, Neurauter A, Gritsch C, Wenzel V, Müller T, et al. A comparison of the combination of epinephrine and vasopressin with lipid emulsion in a porcine model of asphyxial cardiac arrest after intravenous injection of bupivacaine. Anesth Analg. 2008;106(5):1566–71.CrossRefGoogle Scholar
  42. 42.
    Neal JM, et al. The third American Society of Regional Anesthesia and Pain Medicine practice advisory on local anesthetic systemic toxicity: executive summary 2017. Reg Anesth Pain Med. 2018;43(2):113–23.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Preetham J. Suresh
    • 1
  1. 1.Department of AnesthesiologyUniversity of CaliforniaSan DiegoUSA

Personalised recommendations